Page last updated: 2024-09-03

3-(2,4-dimethoxybenzylidene)anabaseine and bay 11-7082

3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with bay 11-7082 in 1 studies

Compound Research Comparison

Studies
(3-(2,4-dimethoxybenzylidene)anabaseine)
Trials
(3-(2,4-dimethoxybenzylidene)anabaseine)
Recent Studies (post-2010)
(3-(2,4-dimethoxybenzylidene)anabaseine)
Studies
(bay 11-7082)
Trials
(bay 11-7082)
Recent Studies (post-2010) (bay 11-7082)
1668815701383

Protein Interaction Comparison

ProteinTaxonomy3-(2,4-dimethoxybenzylidene)anabaseine (IC50)bay 11-7082 (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 20.82
Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)2
Nuclear factor NF-kappa-B p100 subunit Homo sapiens (human)2
Transcription factor p65Homo sapiens (human)2.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chokchaisiri, R; Chuprajob, T; Lin, Y; Lu, X; Shen, X; Sornkaew, N; Suksamrarn, A; Wang, F; Wang, P; Wongkrajang, K; Yang, L; Yang, N; Zhang, G; Zhou, Z1

Other Studies

1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and bay 11-7082

ArticleYear
Discovery of diarylheptanoids that activate α7 nAchR-JAK2-STAT3 signaling in macrophages with anti-inflammatory activity in vitro and in vivo.
    Bioorganic & medicinal chemistry, 2022, 07-15, Volume: 66

    Topics: Animals; Anti-Inflammatory Agents; Diarylheptanoids; Janus Kinase 2; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Sepsis; STAT3 Transcription Factor

2022